Can chatbots help with genetic testing for cancer risk?

byHuntsman Cancer InstituteCredit: CC0 Public DomainIn a study from Huntsman Cancer Institute at the University of Utah (the U) and NYU Langone Perlmutter Cancer Center, researchers found that a

Updated on: September 27,2024

Can chatbots help with genetic testing for cancer risk?

byHuntsman Cancer InstituteCredit: CC0 Public DomainIn a study from Huntsman Cancer Institute at the University of Utah (the U) and NYU Langone Perlmutter Cancer Center, researchers found that a

Updated on:September 27,2024

Why a promising breast cancer drug doesn't work—and how to improve it

by Katherine Fenz,Rockefeller UniversityER-mediated transcriptional resistance to BD inhibition. Credit:Nature Structural & Molecular Biology(2024). DOI: 10.1038/s41594-024-01384

Updated on: September 28,2024

Why a promising breast cancer drug doesn't work—and how to improve it

by Katherine Fenz,Rockefeller UniversityER-mediated transcriptional resistance to BD inhibition. Credit:Nature Structural & Molecular Biology(2024). DOI: 10.1038/s41594-024-01384

Updated on:September 28,2024

Previous cancer linked to long term heightened risk of cardiovascular disease

by British Medical JournalCredit: Pixabay/CC0 Public DomainCancer survivors may be at long term heightened risk of subsequent cardiovascular disease, irrespective of traditional underlying risk f

Updated on: January 28,2024

Previous cancer linked to long term heightened risk of cardiovascular disease

by British Medical JournalCredit: Pixabay/CC0 Public DomainCancer survivors may be at long term heightened risk of subsequent cardiovascular disease, irrespective of traditional underlying risk f

Updated on:January 28,2024

Rare but important gene target found in many tumor types, suggesting new therapy possible

by Georgetown University Medical CenterStephen V. Liu, MD, an associate professor of medicine at Georgetown Lombardi Comprehensive Cancer Center. Credit: Georgetown UniversityA consortium of rese

Updated on: April 20,2024

Rare but important gene target found in many tumor types, suggesting new therapy possible

by Georgetown University Medical CenterStephen V. Liu, MD, an associate professor of medicine at Georgetown Lombardi Comprehensive Cancer Center. Credit: Georgetown UniversityA consortium of rese

Updated on:April 20,2024

Study validates diagnostic assay for Asian cancers

by National University of SingaporeGraphical overview of workflow and coverage of cancer subtypes in the Asian Pan-Cancer Panel. A total of six workdays are required from sample QC to reliable ge

Updated on: February 20,2024

Study validates diagnostic assay for Asian cancers

by National University of SingaporeGraphical overview of workflow and coverage of cancer subtypes in the Asian Pan-Cancer Panel. A total of six workdays are required from sample QC to reliable ge

Updated on:February 20,2024

Novobiocin attacks BRCA-mutated cancer cells from within and without, study shows

byDana-Farber Cancer InstituteEfficacy of POLθ inhibition in HR-deficient cancers requires CD8+T cells.a,bK14-Cre-Brca1f/f;Trp53f/fTNBC tumors from syngeneic FVB/12

Updated on: January 23,2024

Novobiocin attacks BRCA-mutated cancer cells from within and without, study shows

byDana-Farber Cancer InstituteEfficacy of POLθ inhibition in HR-deficient cancers requires CD8+T cells.a,bK14-Cre-Brca1f/f;Trp53f/fTNBC tumors from syngeneic FVB/12

Updated on:January 23,2024

Finally, a tool to predict response to chemotherapy before bladder cancer surgery

by CU Anschutz Medical CampusThomas Flaig, MD, and colleagues show that COXEN may predict which patients will respond to chemotherapy before bladder cancer surgery Credit: University of Colorado

Updated on: March 21,2024

Finally, a tool to predict response to chemotherapy before bladder cancer surgery

by CU Anschutz Medical CampusThomas Flaig, MD, and colleagues show that COXEN may predict which patients will respond to chemotherapy before bladder cancer surgery Credit: University of Colorado

Updated on:March 21,2024

Study identifies how cancer-causing gene regulates genetic variation in prostate cancer

by Queen Mary, University of LondonGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111404Researchers from Barts Cancer Institute (BCI) at Queen Mary Universi

Updated on: January 30,2024

Study identifies how cancer-causing gene regulates genetic variation in prostate cancer

by Queen Mary, University of LondonGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111404Researchers from Barts Cancer Institute (BCI) at Queen Mary Universi

Updated on:January 30,2024

First randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer

by ECOG-ACRIN Cancer Research GroupCredit: Pixabay/CC0 Public DomainThe ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) will present data from PROSPER RCC (EA8143), the first randomized phase 3 trial of

Updated on: January 04,2024

First randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer

by ECOG-ACRIN Cancer Research GroupCredit: Pixabay/CC0 Public DomainThe ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) will present data from PROSPER RCC (EA8143), the first randomized phase 3 trial of

Updated on:January 04,2024

Optimizing tobacco cessation treatment with lung cancer screening

byUniversity of MinnesotaVisual Abstract.Optimizing Longitudinal Tobacco Cessation Treatment in Lung Cancer Screening. Credit:JAMA Network Open(2023). DOI: 10.1001/jamanetworko

Updated on: January 07,2024

Optimizing tobacco cessation treatment with lung cancer screening

byUniversity of MinnesotaVisual Abstract.Optimizing Longitudinal Tobacco Cessation Treatment in Lung Cancer Screening. Credit:JAMA Network Open(2023). DOI: 10.1001/jamanetworko

Updated on:January 07,2024

A window into the changing tumor microenvironment

by Ludwig Cancer ResearchGraphical abstract. Credit:iScience(2022). DOI: 10.1016/j.isci.2022.104570Researchers led by Ludwig Lausanne's Anoek Zomer, Davide Croci and Johanna Joyce

Updated on: February 18,2024

A window into the changing tumor microenvironment

by Ludwig Cancer ResearchGraphical abstract. Credit:iScience(2022). DOI: 10.1016/j.isci.2022.104570Researchers led by Ludwig Lausanne's Anoek Zomer, Davide Croci and Johanna Joyce

Updated on:February 18,2024

Allogenic hematopoietic cell transplant a viable option for high-risk myelodysplastic syndrome, study suggests

byDana-Farber Cancer InstituteClinical outcomes by TP53 allelic state. (A) OS by TP53 allelic state. (B) Cumulative incidence of MDS relapse or progression to AML by TP53 allelic state, with dea

Updated on: January 16,2024

Allogenic hematopoietic cell transplant a viable option for high-risk myelodysplastic syndrome, study suggests

byDana-Farber Cancer InstituteClinical outcomes by TP53 allelic state. (A) OS by TP53 allelic state. (B) Cumulative incidence of MDS relapse or progression to AML by TP53 allelic state, with dea

Updated on:January 16,2024